Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Amide. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN105859549A reveals a novel oxidation chlorination route for high-purity agrochemical intermediate manufacturing with substantial cost reduction and supply chain reliability.
Patent CN115677599A details a green synthesis route for this key veterinary API intermediate, offering higher purity and reduced environmental impact compared to traditional pyridine-based methods.
Patent CN107011263A reveals copper-catalyzed amide synthesis offering cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing processes globally.
Patent CN106977454A details a copper-catalyzed route for N-phenyl-N-8-quinolyl-benzamide offering high yield and supply chain efficiency for pharmaceutical intermediates manufacturing.
Patent CN1293669A discloses selective dopamine D4 antagonists for schizophrenia. We offer scalable synthesis and cost-effective supply chain solutions.
Patent CN104151220B reveals a novel synthesis route for dithiooxamide derivatives offering high purity and simplified manufacturing for global supply chains.
Patent CN120554257A details a novel ammoniation method enhancing purity and yield while reducing waste for reliable pharmaceutical intermediate supply chains.
Patent CN112209965A details a high-yield rhodium-catalyzed asymmetric hydrogenation route for chiral beta-aminophosphine precursors, offering significant supply chain and cost advantages.
Novel room temperature synthesis yields over 90 percent. Reduces steps and improves supply chain reliability for pharmaceutical intermediates manufacturing globally.
Patent CN106966973A reveals copper-catalyzed synthesis. Offers high yield and supply chain stability for pharmaceutical intermediates. Cost effective production method.
Novel iron-catalyzed para-C-H functionalization patent CN120289316A offers mild conditions and high yields for pharmaceutical intermediates manufacturing supply chain.
Patent CN111005033A reveals a green electroreduction route for sildenafil intermediates, eliminating heavy metals and toxic reducers for cost-effective API production.
Patent CN102134212B reveals a streamlined oxiracetam synthesis using 4-chloroacetyl acetic ester, offering superior yield and purity for pharmaceutical manufacturing.
Patent CN110818576B reveals a novel rare earth catalyzed synthesis of secondary amines. High yield, mild conditions, and cost-effective supply chain solutions for pharma.
Patent CN101914052B reveals a cost-effective oxiracetam synthesis using 3-chloro-2-hydroxy propionitrile, offering high purity and scalable manufacturing for pharmaceutical supply chains.
Patent CN118978656B reveals stable porous organic cages for iodine adsorption. Discover cost reduction in environmental chemical manufacturing and supply chain advantages.
Patent CN1409702A details a cost-effective asymmetric synthesis of Casodex enantiomers using citramalic acid, offering supply chain advantages over proline-based methods.
Patent CN115108932A reveals a novel Ru-catalyzed oxidative amidation using DMF. This method offers significant cost reduction in pharmaceutical intermediates manufacturing and enhanced supply chain reliability.
Patent CN111592533A reveals a high-yield route for fungicidal intermediates. Discover cost-effective synthesis and scalable manufacturing insights for global supply chains.
Patent CN108314646B reveals a novel Pd/Ni-MOF catalyst for Apalutamide intermediates, offering high purity, recyclability, and significant cost reduction in API manufacturing.